The appropriate integration of surgery and chemotherapy in the management of non-seminomatous germ-cell tumors (NSGCT) has resulted in overall survival rates of over 90% for all stages of the disease.

Background A 60-year-old man with a history of atherosclerotic disease of the carotid and coronary vasculature presented with lower back pain and acute renal failure. Imaging studies revealed ...